Investigation of TEST (Transcranial Electric Stimulation Therapy) for Chronic Pain
1 other identifier
interventional
6
1 country
1
Brief Summary
The goal in this study is to investigate TEST (Transcranial Electric Stimulation Therapy) for chronic pain. It requires an inpatient stay on our research unit of about a month. The study is designed to address the cognitive and emotional aspects of chronic pain and other conditions that often accompany this disorder, such as major depression or drug use.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable chronic-pain
Started Jan 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 28, 2021
CompletedFirst Posted
Study publicly available on registry
November 9, 2021
CompletedStudy Start
First participant enrolled
January 2, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 16, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 17, 2024
CompletedResults Posted
Study results publicly available
April 1, 2025
CompletedApril 1, 2025
March 1, 2025
1 year
October 28, 2021
January 17, 2025
March 31, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Feasibility Will be Assessed by the Percent of Participants Who Complete
Feasibility will be assessed by the percent of participants start study procedures and complete these
4 weeks
Study Arms (1)
open label
OTHERthis is an open label study
Interventions
Eligibility Criteria
You may qualify if:
- adults (ages 22 to 60) who understand all procedures and have the ability to provide informed consent, with a score on the Mini-Mental Status Exam of at least 24;
- participants experiencing chronic pain, with ongoing pain symptoms, and score on the Brief Pain Inventory of \> 5 on question #3 (which asks about maximal pain in the past 24 hours) or \> 5 on question #5 (which asks about average pain in the past 24 hours);
- a diagnosis of chronic postoperative pain, low back pain, musculoskeletal pain, fibromyalgia, visceral pain or neuropathic pain, including complex regional pain syndrome or peripheral neuropathy;
- no significant changes in pain medications for at least one month prior to study entry.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
1051 Riverside Drive
New York, New York, 10032, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Diana Martinez
- Organization
- NYSPI
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DEVICE FEASIBILITY
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor in Psychaitry
Study Record Dates
First Submitted
October 28, 2021
First Posted
November 9, 2021
Study Start
January 2, 2023
Primary Completion
January 16, 2024
Study Completion
January 17, 2024
Last Updated
April 1, 2025
Results First Posted
April 1, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share